^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Cymerin (ranimustine)

    i
    Associations
    News

    Trials

    Company:
    Mitsubishi Tanabe
    Drug class:
    Alkylating agent
    Related drugs:
    Associations
    News

    Trials

    Apply
    Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 (NCT01173887)
    Phase 2
    Kyowa Kirin Co., Ltd.
    Completed
    Last update posted :
    03/30/2017
    Initiation :
    07/01/2010
    Primary completion :
    04/01/2012
    Completion :
    04/01/2012
    CCR4
    |
    carboplatin • doxorubicin hydrochloride • cyclophosphamide • Poteligeo (mogamulizumab-kpkc) • Cymerin (ranimustine) • vindesine